The role of CD44 in fetal and adult hematopoietic stem cell regulation

Haematologica

Volumn 101, Issue 1, 2016, Pages 26-37

  Cao, Huimin ^a,b   Heazlewood, Shen Y ^a,b   Williams, Brenda ^a,b   Cardozo, Daniela ^a,b   Nigro, Julie ^a   Oteiza, Ana ^c   Nilsson, Susan K ^a,b  

^a CSIRO   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; STROMAL CELL DERIVED FACTOR 1ALPHA; CD44 PROTEIN, MOUSE; CXCL12 PROTEIN, MOUSE; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS ASSAY; DEVELOPMENTAL STAGE; ENGRAFTMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; ANIMAL; CELL MOTION; CYTOLOGY; FETUS; GENETICS; HEMATOPOIETIC STEM CELL; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD44; CELL MOVEMENT; CHEMOKINE CXCL12; FETUS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; MICE; MICE, KNOCKOUT;

EID: 84952910181     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2015.135921     Document Type: Article

References (69)

1. Goodison S, Urquidi V, Tarin D. CD44 cell adhesion molecules. Mol Pathol. 1999;52(4):189-196.
2. Wheatley SC, Isacke CM, Crossley PH. Restricted expression of the hyaluronan receptor, CD44, during postimplantation mouse embryogenesis suggests key roles in tissue formation and patterning. Development. 1993;119(2):295-306.
3. Culty M, Nguyen HA, Underhill CB. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol. 1992;116(4):1055-1062.
4. Trochon V, Mabilat C, Bertrand P, et al. Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro. Int J Cancer. 1996;66(5):664-668.
5. Jain M, He Q, Lee WS, et al. Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. J Clin Invest. 1996;98(3):877.
6. McKee CM, Penno MB, Cowman M, et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest. 1996;98(10):2403-2413.
7. Khaldoyanidi S, Achtnich M, Hehlmann R, et al. Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: inverse correlation between expression and tumor progression. Leuk Res. 1996;20(10):839-851.
8. Gunthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 1991;65(1):13-24.
9. Birch M, Mitchell S, Hart IR. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Res. 1991;51(24):6660-6667.
10. Aruffo A, Stamenkovic I, Melnick M, et al. CD44 is the principal cell surface receptor for hyaluronate. Cell. 1990;61(7):1303-1313.
11. Faassen AE, Schrager JA, Klein DJ, et al. A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J Cell Biol. 1992;116(2):521-531.
12. Verfaillie CM, Benis A, Iida J, et al. Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor. Blood. 1994;84(6):1802-1811.
13. Dimitroff CJ, Lee JY, Rafii S, et al. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J Cell Biol. 2001;153(6):1277-1286.
14. Lesley J, English N, Perschl A, et al. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med. 1995;182(2):431-437.
15. Brown KL, Maiti A, Johnson P. Role of sulfation in CD44-mediated hyaluronan binding induced by inflammatory mediators in human CD14(+) peripheral blood monocytes. J Immunol. 2001;167(9):5367-5374.
16. Harada H, Takahashi M. CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and-2. J Biol Chem. 2007;282(8):5597-5607.
17. Weigel PH, Hascall VC, Tammi M. Hyaluronan synthases. J Biol Chem. 1997;272(22):13997-14000.
18. Nilsson SK, Haylock DN, Johnston HM, et al. Hyaluronan is synthesized by primitive hemopoietic cells, participates in their lodgment at the endosteum following transplantation, and is involved in the regulation of their proliferation and differentiation in vitro. Blood. 2003;101(3):856-862.
19. Legras S, Levesque JP, Charrad R, et al. CD44-mediated adhesiveness of human hematopoietic progenitors to hyaluronan is modulated by cytokines. Blood. 1997;89(6):1905-1914.
20. Avigdor A, Goichberg P, Shivtiel S, et al. CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood. 2004;103(8):2981-2989.
21. Miyake K, Medina KL, Hayashi S, et al. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med. 1990;171(2):477-488.
22. O'Neill HC. Antibody which defines a subset of bone marrow cells that can migrate to thymus. Immunology. 1989;68(1):59-65.
23. Zeng H, Chen Y, Yu M, et al. T cell receptor-mediated activation of CD4+CD44hi T cells bypasses Bcl10: an implication of differential NF-kappaB dependence of naive and memory T cells during T cell receptormediated responses. J Biol Chem. 2008;283(36):24392-24399.
24. Kansas GS, Muirhead MJ, Dailey MO. Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans. Blood. 1990;76(12):2483-2492.
25. Vermeulen M, Le Pesteur F, Gagnerault MC, et al. Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood. 1998;92(3):894-900.
26. Jalkanen S, Reichert RA, Gallatin WM, et al. Homing receptors and the control of lymphocyte migration. Immunol Rev. 1986;91:39-60.
27. Jalkanen S, Bargatze RF, de los Toyos J, et al. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol. 1987;105(2):983-990.
28. Huet S, Groux H, Caillou B, et al. CD44 contributes to T cell activation. J Immunol. 1989;143(3):798-801.
29. Shimizu Y, Van Seventer GA, Siraganian R, et al. Dual role of the CD44 molecule in T cell adhesion and activation. J Immunol. 1989;143(8):2457-2463.
30. Denning SM, Le PT, Singer KH, et al. Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J Immunol. 1990;144(1):7-15.
31. Khaldoyanidi S, Denzel A, Zoller M. Requirement for CD44 in proliferation and homing of hematopoietic precursor cells. J Leukoc Biol. 1996;60(5):579-592.
32. Zoller M. CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells. Front Immunol. 2015;6:235.
33. Ren AH, Zhang Y, Zhao YL, et al. [Comparative study of differentially expressed genes in mouse bone marrow and fetal liver cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003;11(5):444-449.
34. Huang H, Auerbach R. Identification and characterization of hematopoietic stem cells from the yolk sac of the early mouse embryo. Proc Natl Acad Sci USA. 1993;90(21):10110-10114.
35. Schmits R, Filmus J, Gerwin N, et al. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood. 1997;90(6):2217-2233.
36. Ellis SL, Heazlewood SY, Williams B, et al. The role of Tenascin C in the lymphoid progenitor cell niche. Exp Hematol. 2013;41(12):1050-1061.
37. Cao H, Williams B, Nilsson SK. Investigating the Interaction Between Hemopoietic Stem Cells and Their Niche During Embryonic Development: Optimizing the Isolation of Fetal and Newborn Stem Cells From Liver, Spleen, and Bone Marrow. In: Bunting K, ed. Hematopoietic Stem Cell Protocols. USA: Humana Press, 2014.
38. Grassinger J, Haylock DN, Williams B, et al. Phenotypically identical hemopoietic stem cells isolated from different regions of bone marrow have different biologic potential. Blood. 2010;116(17):3185-3196.
39. Grassinger J, Haylock DN, Storan MJ, et al. Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with alpha9beta1 and alpha4beta1 integrins. Blood. 2009;114(1):49-59.
40. Nilsson SK, Johnston HM, Coverdale JA. Spatial localization of transplanted hemopoietic stem cells: inferences for the local ization of stem cell niches. Blood. 2001; 97(8):2293-2299.
41. Smith LH, Clayton ML. Distribution of injected 59Fe in mice. Exp Hematol. 1970;20:82-86.
42. Shaaban AF, Kim HB, Milner R, et al. A kinetic model for the homing and migration of prenatally transplanted marrow. Blood. 1999;94(9):3251-3257.
43. Nilsson SK, Dooner MS, Tiarks CY, et al. Potential and distribution of transplanted hematopoietic stem cells in a nonablated mouse model. Blood. 1997;89(11):4013-4020.
44. Daldrup-Link HE, Link TM, Rummeny EJ, et al. Assessing permeability alterations of the blood-bone marrow barrier due to total body irradiation: in vivo quantification with contrast enhanced magnetic resonance imaging. Bone Marrow Transplant. 2000;25(1):71-78.
45. Shirota T, Tavassoli M. Alterations of bone marrow sinus endothelium induced by ionizing irradiation: implications in the homing of intravenously transplanted marrow cells. Blood Cells. 1992;18(2):197-214.
46. Gaugler MH, Squiban C, Mouthon MA, et al. Irradiation enhances the support of haemopoietic cell transmigration, proliferation and differentiation by endothelial cells. Br J Haematol. 2001;113(4):940-950.
47. Cui J, Wahl RL, Shen T, et al. Bone marrow cell trafficking following intravenous administration. Br J Haematol. 1999;107(4): 895-902.
48. Ellis SL, Grassinger J, Jones A, et al. The relationship between bone, hemopoietic stem cells, and vasculature. Blood. 2011;118(6):1516-1524.
49. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol. 1981;126(4):1614-1619.
50. Szilvassy SJ, Fraser CC, Eaves CJ, et al. Retrovirus-mediated gene transfer to purified hemopoietic stem cells with long-term lympho-myelopoietic repopulating ability. Proc Natl Acad Sci USA. 1989;86(22):8798-8802.
51. Harrison DE. Competitive repopulation: a new assay for long-term stem cell functional capacity. Blood. 1980;55(1):77-81.
52. Harrison DE, Jordan CT, Zhong RK, et al. Primitive hemopoietic stem cells: direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations. Exp Hematol. 1993;21(2):206-219.
53. Morrison SJ, Hemmati HD, Wandycz AM, et al. The purification and characterization of fetal liver hematopoietic stem cells. Proc Natl Acad Sci USA. 1995;92(22):10302-10306.
54. Kajiume T, Ninomiya Y, Ishihara H, et al. Polycomb group gene mel-18 modulates the self-renewal activity and cell cycle status of hematopoietic stem cells. Exp Hematol. 2004;32(6):571-578.
55. Qian H, Buza-Vidas N, Hyland CD, et al. Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell. 2007;1(6):671-684.
56. Ara T, Tokoyoda K, Sugiyama T, et al. Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny. Immunity. 2003;19(2):257-267.
57. Nabors LK, Wang LD, Wagers AJ, et al. Overlapping roles for endothelial selectins in murine hematopoietic stem/progenitor cell homing to bone marrow. Exp Hematol. 2013;41(7):588-596.
58. Lewinsohn DM, Nagler A, Ginzton N, et al. Hematopoietic progenitor cell expression of the H-CAM (CD44) homing-associated adhesion molecule. Blood. 1990;75(3):589-595.
59. Oostendorp RA, Ghaffari S, Eaves CJ. Kinetics of in vivo homing and recruitment into cycle of hematopoietic cells are organspecific but CD44-independent. Bone Marrow Transplant. 2000;26(5):559-566.
60. Ema H, Nakauchi H. Expansion of hematopoietic stem cells in the developing liver of a mouse embryo. Blood. 2000;95(7): 2284-2288.
61. Kikuchi K, Kondo M. Developmental switch of mouse hematopoietic stem cells from fetal to adult type occurs in bone marrow after birth. Proc Natl Acad Sci USA. 2006;103(47):17852-17857.
62. Waterstrat A, Liang Y, Swiderski CF, et al. Congenic interval of CD45/Ly-5 congenic mice contains multiple genes that may influence hematopoietic stem cell engraftment. Blood. 2010;115(2):408-417.
63. Tzircotis G, Thorne RF, Isacke CM. Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding. J Cell Sci. 2005;118(Pt 21):5119-5128.
64. Haylock DN, Williams B, Johnston HM, et al. Hemopoietic stem cells with higher hemopoietic potential reside at the bone marrow endosteum. Stem Cells. 2007;25(4):1062-1069.
65. Protin U, Schweighoffer T, Jochum W, et al. CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets. J Immunol. 1999;163(9):4917-4923.
66. Cao H, Oteiza A, Nilsson SK. Understanding the role of the microenvironment during definitive hemopoietic development. Exp Hematol. 2013; 41(9):761-768.
67. Petit I, Szyper-Kravitz M, Nagler A, et al. GCSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol. 2002;3(7): 687-694.
68. Chou S, Lodish HF. Fetal liver hepatic progenitors are supportive stromal cells for hematopoietic stem cells. Proc Natl Acad Sci USA. 2010;107(17):7799-7804.
69. Olofsson B, Porsch H, Heldin P. Knockdown of CD44 regulates endothelial cell differentiation via NFkappaB-mediated chemokine production. PLoS One. 2014;9 (3):e90921.